`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.,
`Petitioner,
`
`v.
`
`TELEFLEX INNOVATIONS S.À.R.L.,
`Patent Owner.
`
`
`Case IPR2020-00128
`Patent RE 45,380
`
`
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`EXHIBIT LIST
`
`
`Exhibit Description
`1001 U.S. Patent No. RE45,380 (“the ’380 patent”)
`1002
`File history for U.S. Patent No. 8,292,850
`1003
`File history for U.S. Patent No. RE45,380
`1004 Assignment record of the ’380 patent from the USPTO assignment
`database
`1005 Declaration of Doctor Stephen JD Brecker, M.D.
`1006
`Curriculum Vitae of Doctor Stephen JD Brecker, M.D.
`1007 U.S. Patent No. 7,736,355 (“Itou”)
`1008 U.S. Patent No. 7,604,612 (“Ressemann”)
`1009 U.S. Patent No. 5,439,445 (“Kontos”)
`1010
`New Method to Increase a Backup Support of a 6 French Guiding
`Coronary Catheter, Catheterization and Cardiovascular Interventions
`63: 452-456 (2004) (“Takahashi”)
`Excerpt of prosecution history of U.S. Patent No. 8,048,032
`(Application 11/416,629) (Amendment and Response, April 6, 2009)
`Joint Claim Construction Statement in QXMedical, LLC v. Vascular
`Solutions, Inc., D. Minn., No. 17-cv-01969 (January 10, 2018), D.I.
`36; D.I. 36-1.
`1013 Markman Order in QXMedical, LLC v. Vascular Solutions, Inc., D.
`Minn., No. 17-cv-01969 (October 30, 2018), D.I. 102
`1014 Meads, C., et al., Coronary artery stents in the treatment of ischaemic
`heart disease: a rapid and systematic review, Health Technology
`Assessment 2000 4(23) (“Meads”)
`Excerpt from Grossman’s Cardiac Catheterization, Angiography, and
`Intervention (6th edition) (2000) (chapters 1, 4, 11, 23-25).
`1016 US Patent Publication 2003/0233117 (“Adams ’117”)
`1017 U.S. Patent No. 5,902,290 (“Peacock”)
`1018 U.S. Patent No. 5,891,056 (“Ramzipoor”)
`1019 U.S. Patent No. 6,398,773 (“Bagaoisan”)
`
`1011
`
`1012
`
`1015
`
`1
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1021
`
`1024
`
`Exhibit Description
`1020 Mehan, Coronary Angioplasty through 4 French Diagnostic
`Catheters, Catheterization and Cardiovascular Interventions 30:22-26
`(1993) (“Mehan”)
`Excerpt of prosecution history for application 11/232,876 (Office
`Action, 6/20/09)
`Cordis, Instructions for Use, CYPHER™ (April 2003)
`1022
`1023 Medtronic, Summary of Safety and Effectiveness Data, Driver™
`Coronary Stent System (October 1, 2003)
`Boston Scientific, Summary of Safety and Effectiveness Data,
`TAXUS™ Express2™ Drug-Eluting Coronary Stent System (March
`4, 2004)
`1025 U.S. Publication Application No. 2005/0015073 (“Kataishi”)
`1026 U.S. Patent No. 5,489,278 (“Abrahamson”)
`1027 U.S. Patent No. RE45,776 (“Root”)
`1028
`Baim, Randomized Trial of a Distal Embolic Protection Device
`During Percutaneous Intervention of Saphenous Vein Aorto-
`Coronary Bypass Grafts, Circulation 105:1285-1290 (2002) (“Baim”)
`Limbruno, Mechanical Prevention of Distal Embolization During
`Primary Angioplasty, Circulation 108:171-176 (2003) (“Limbruno”)
`1030 U.S. Patent No. 5,413,560 (“Solar ’560”)
`1031
`Schöbel, Percutaneous Coronary Interventions Using a New 5
`French Guiding Catheter: Results of a Prospective Study,
`Catheterization & Cardiovascular Interventions 53:308-312 (2001)
`(“Schöbel”)
`The sliding rail system (monorail): description of a new technique for
`intravascular instrumentation and its application to coronary
`angioplasty, Z. Kardio. 76:Supp. 6, 119-122 (1987) (“Bonzel”)
`1033 U.S. Publication Application No. 2004/0236215 (Mihara)
`1034 U.S. Patent No. 5,527,292 (“Adams ’292”)
`1035 U.S. Publication Application No. 2004/0010280 (“Adams ’280”)
`1036 Williams et al., Percutaneous Coronary Intervention in the Current
`Era Compared with 1985-1986, Circulation (2000) 102:2945-2951.
`
`1032
`
`1029
`
`2
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1040
`
`1041
`
`Exhibit Description
`1037 Dorros, G., et al., Coronary Angioplasty in Patients with Prior
`Coronary Artery Bypass Surgery, Cardiology Clinics 7(4): 791-803
`(1989)
`1038 Ozaki et al, New Stent Technologies, Progress in Cardiovascular
`Disease 2:129-140 (1996)
`1039 Urban et al., Coronary stenting through 6 French Guiding Catheters,
`Catheterization and Cardiovascular Diagnosis (1993) 28:263-266
`Excerpt of McGraw-Hill Dictionary of Scientific and Technical
`Terms (5th edition) (1994) (defining “flexural modulus”)
`Excerpt from Kern’s The Interventional Cardiac Catheterization
`Handbook (2nd edition) (2004) (chapter 1)).
`1042 Declaration of Dr. Richard A. Hillstead, Ph.D.
`1043
`Curriculum Vitae of Dr. Richard A. Hillstead, Ph.D.
`1044 U.S. Patent No. 5,961,510 (“Fugoso”)
`1045 U.S. Patent No. 6,199,262 (“Martin”)
`1046 U.S. Patent No. 6,042,578 (“Dinh”)
`1047 WO 97/37713 (“Truckai”)
`1048
`Terumo Heartrail II product literature
`1049 Medtronic Launcher product literature
`1050 U.S. Patent No. 5,980,486 (“Enger”)
`1051 U.S. Patent No. 5,911,715 (“Berg”)
`1052 U.S. Patent No. 5,545,149 (“Brin”)
`1053 U.S. Patent No. 5,720,300 (“Fagan”)
`1054 U.S. Patent No. 5,120,323 (“Shockey”)
`1055
`Sakurada, Improved Performance of a New Thrombus Aspiration
`Catheter: Outcomes From In Vitro Experiments and a
`Case Presentation (“Sakurada”)
`1056 Nordenstrom, New Instruments for Catheterization and
`Angiocardiography (“Nordenstrom”)
`1057 U.S. Patent No. 5,445,625 (“Voda”)
`
`3
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`Exhibit Description
`1058 U.S. Patent No. 6,595,952 (“Forsberg”)
`1059 U.S. Patent No. 6,860,876 (“Chen”)
`1060 U.S. Patent No. 6,638,268 (“Niazi”)
`1061 U.S. Patent No. 5,690,613 (“Verbeek”)
`1062
`lserson, J.-F.-B. Charrière: The Man Behind the “French” Gauge,
`The Journal of Emergency Medicine. Vol. 5 pp 545-548 (1987)
`1063 U.S. Publication Application No. 2003/0195546 (“Solar ’546”)
`1064 QXMédical, LLC’s Opening Claim Construction
`Memorandum QXMedical, LLC v. Vascular Solutions, Inc., D. Minn.,
`No. 17-cv-01969 (March 14, 2018), D.I. 56
`1065 U.S. Patent No. 4,000,739 (“Stevens”)
`1066
`EP 0 881 921 B1 (“Lee”)
`1067 U.S. Patent No. 5,451,209 (“Ainsworth”)
`1068 Defendants’ Memorandum in Opposition to Plaintiff’s Summary
`Judgment Motion and in Support of Defendants’ Summary Judgment
`Motion, QXMedical, LLC v. Vascular Solutions LLC et al., 17-cv-
`01969-PJS-TNL (D. Minn 2019)
`Excerpt of prosecution history for application 14/195,435 (Office
`Action, 10/06/15)
`1070 Metz, Comparison of 6f with 7f and 8f guiding catheters for elective
`coronary angioplasty: Results of a prospective, multicenter,
`randomized trial, American Heart Journal. Vol. 134, Number 1, pp
`132-137 (“Metz”)
`Feldman, Coronary Angioplasty Using New 6 French Guiding
`Catheters, Catheterization and Cardiovascular Diagnosis 23:93-99
`(1991) (“Feldman”)
`1072 U.S. Patent No. 5,704,926 (“Sutton”)
`1073
`Plaintiffs’ Memorandum in Support of Motion for Preliminary
`Injunction, Vascular Solutions LLC et al. v. Medtronic, Inc., 19:cv-
`01760-PJS-TNL
`
`1071
`
`1069
`
`4
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1075
`
`1078
`1079
`
`Exhibit Description
`1074 Yokoyama, Feasibility and safety of thrombectomy with TVAC
`aspiration catheter system for patients with acute myocardial
`infarction, Heart Vessels (2006) 21:1–7 (“Yokoyama”)
`Excerpt from Plaintiff’s infringement allegations in Vascular
`Solutions, LLC. v. Medtronic, Inc., D. Minn., No. 19-cv-01760
`(October 11, 2019), D.I. 1-14.
`1076 U.S. Patent No. 5,860,963 (“Azam”)
`1077
`10/16/2019 Deposition of Peter Keith in Vascular Solutions, LLC. v.
`Medtronic, Inc., D. Minn., No. 19-cv-01760
`Sylvia Hall-Ellis’s Librarian Declaration
`Complaint in Vascular Solutions, LLC. v. Medtronic, Inc., D. Minn.,
`No. 19-cv-01760 (October 11, 2019), D.I. 1-14.
`1080 U.S. Patent No. 5,061,273 (“Yock”)
`1081
`Intentionally Left Blank
`1082 Declaration of Peter Keith in Support of Plaintiffs’ Motion for
`Preliminary Injunction, Vascular Solutions LLC et al. v. Medtronic,
`Inc., 19:cv-01760-PJS-TNL (July 12, 2019)
`Joint Fed. R. C. P. 26(f) Report [Excerpt], Vascular Solutions LLC et
`al. v. Medtronic, Inc., 19:cv-01760-PJS-TNL
`Plaintiffs’ Objections and Responses to Interrogatories [Excerpt],
`Vascular Solutions LLC et al. v. Medtronic, Inc., 19:cv-01760-PJS-
`TNL
`Teleconference Transcript from March 23, 2020
`Protective Order, Vascular Solutions LLC et al. v. Medtronic, Inc.,
`19:cv-01760-PJS-TNL
`Teleconference Transcript from April 17, 2020
`Preliminary Injunction Order, Vascular Solutions LLC et al. v.
`Medtronic, Inc., 19:cv-01760-PJS-TNL (April 9, 2020)
`Chart showing Judge Schiltz’s Trial Ready Dates
`Pretrial Scheduling Order in QXMedical, LLC v. Vascular Solutions,
`Inc., D. Minn., No. 17-cv-01969 (September 1, 2017), D.I. 20
`
`1085
`1086
`
`1083
`
`1084
`
`1087
`1088
`
`1089
`1090
`
`5
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1092
`
`1093
`
`1095
`
`Exhibit Description
`1091
`Third Amended Pretrial Scheduling Order in QXMedical, LLC v.
`Vascular Solutions, Inc., D. Minn., No. 17-cv-01969 (December 11,
`2018), D.I. 106
`Trial Notice and Final Pretrial Order in QXMedical, LLC v. Vascular
`Solutions, Inc., D. Minn., No. 17-cv-01969 (October 3, 2019), D.I.
`157
`Screenshot from Docket Navigator regarding Judge Schiltz’s Motions
`to Stay Pending Inter Partes Review
`1094 Motion to Stay Order in QXMedical, LLC v. Vascular Solutions, Inc.,
`D. Minn., No. 17-cv-01969 (December 26, 2019)
`Plaintiffs’ Infringement Disclosures in Vascular Solutions LLC et al.
`v. Medtronic, Inc., 19:cv-01760-PJS-TNL (March 1, 2020)
`Teleconference Transcript from May 15, 2020
`1096
`1097 Declaration of William E. Manske in Support of Motion for Pro Hac
`Vice
`1098 Declaration of Emily J. Tremblay in Support of Motion for Pro Hac
`Vice
`Teleconference Transcript from October 7, 2020
`1099
`1100 Order Granting Motion to Stay (UNSEALED 9.3.2020) in Vascular
`Solutions LLC et al. v. Medtronic, Inc., 19:cv-01760-PJS-TNL (July
`7, 2020)
`1101 Order Overruling Appeal/Objection of Magistrate Judge Decision to
`District Judge in Vascular Solutions LLC et al. v. Medtronic, Inc.,
`19:cv-01760-PJS-TNL (September 3, 2020)
`1102 Order Lifting Stay in Horton, Inc. v. Kit Masters, Inc., Civ. No. 08-
`6291 (D. Minn.)
`Teleconference Transcript from October 23, 2020
`[Reserved]
`Teleconference Transcript from November 9, 2020
`[Reserved]
`[Reserved]
`
`1103
`1104
`1105
`1106
`1107
`
`6
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`Exhibit Description
`1108
`Transcript from the June 20, 2018 deposition of Gregg Sutton in
`QXMedical, LLC v. Vascular Solutions, Inc., D. Minn., No. 17-cv-
`01969 [PROTECTIVE ORDER MATERIAL]
`1109 Gregg Sutton Lab Notebook #83
`1110
`[Reserved]
`1111
`[Reserved]
`1112
`[Reserved]
`1113
`[Reserved]
`1114
`Transcript from the June 27, 2013 deposition of Howard Charles Root
`in Vascular Solutions, Inc. v. Boston Scientific Corp., D. Minn., No.
`13-cv-01172 [PROTECTIVE ORDER MATERIAL]
`Transcript from the June 15, 2018 deposition of Howard Root in
`QXMedical, LLC v. Vascular Solutions, Inc., D. Minn., No. 17-cv-
`01969 [PROTECTIVE ORDER MATERIAL]
`[Intentionally left blank]
`
`1115
`
`1116-
`1754
`1755
`
`1756
`1757
`1758
`
`1759
`
`1760
`
`1761
`
`1762
`1763
`
` Declaration of Paul Zalesky in Support of Petitioners’ Reply to Patent
`Owner’s Response Addressing Conception and Reduction to Practice
` Transcript from the October 29, 2020 deposition of Steven Erb
` Transcript from the November 6, 2020 deposition of Gregg Sutton
` VSIMDT00030667 – Jeff Welch Lab Notebook #82 [PROTECTIVE
`ORDER MATERIAL]
` VSIQXM_E00005987 – Memo re: GuideLiner OTW Meeting Notes
`[PROTECTIVE ORDER MATERIAL]
` VSIMDT00030439 – Jim Kauphusman Lab Notebook #53
`[PROTECTIVE ORDER MATERIAL]
` VSIMDT00030532 – Katie Mytty Lab Notebook #75
`[PROTECTIVE ORDER MATERIAL]
` Transcript from the November 13, 2020 deposition of Howard Root
` VSIQXM_E00005991 – Concept Drawing GuideLiner OTW
`[PROTECTIVE ORDER MATERIAL]
`
`7
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1766
`
`1767
`
`1768
`
`1769
`
`1770
`
`1771
`1772
`1773
`
`1774
`
`1775
`
`Exhibit Description
` Transcript from the December 1, 2020 deposition of Peter T. Keith
`1764
`1765
` VSIQXM_E00006262 – GuideLiner Concept Drawing
`[PROTECTIVE ORDER MATERIAL]
` Transcript from the November 12, 2020 deposition of Deborah
`Schmalz
` VSIQXM_E00006206 – Product Requirements: GuideLiner (May 4,
`2009) [PROTECTIVE ORDER MATERIAL]
` VSIMDT00030188 – Special Work Order Number Assignment Log
`[PROTECTIVE ORDER MATERIAL]
` VSIMDT00130107 – R&D Device Idea List [PROTECTIVE
`ORDER MATERIAL]
` VSIMDT00033799 – GuideLiner Overview, Perfect Pitch & FAQs
`[PROTECTIVE ORDER MATERIAL]
` FDA, Design Control Guidance for Medical Device Manufacturers
` DHHS, FDA 21 CFR Parts 808, 812, and 820
` Root, Howard, Cardiac Arrest: Five Heart-Stopping Years as a CEO
`on the Feds’ Hit-List, Chapter 4.
` VSIMDT00030223 – Katie Mytty Lab Notebook #101
`[PROTECTIVE ORDER MATERIAL]
` VSIQXM_E00006238 – Guideliner Design/Phase End Review
`Meeting Record (January 30, 2009) [PROTECTIVE ORDER
`MATERIAL]
` VSIMDT00030001 – Vascular Solutions 2005 Annual Report
` VSIMDT00129936 – Vascular Solutions 2006 Annual Report
` VSIMDT00029949 – Twin-Pass, Skyway & Micro-Introducers slide
`deck [PROTECTIVE ORDER MATERIAL]
` VSIMDT00031716 – VSI Marketing Review – April 2005
`[PROTECTIVE ORDER MATERIAL]
` Summary of Safety and Effectiveness for Twin-Pass™ Dual Access
`Catheter
` Summary of Safety and Effectiveness for Skyway™ Support Catheter
`
`1776
`1777
`1778
`
`1779
`
`1780
`
`1781
`
`8
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1783
`
`1784
`
`1785
`1786
`
`1787
`
`1788
`
`Exhibit Description
` VSIMDT00128878 – VSI slide deck: World Sales Meeting January
`1782
`2007 [PROTECTIVE ORDER MATERIAL]
` VSIMDT00037621 – Invoice from Nitinol Devices & Components
`[PROTECTIVE ORDER MATERIAL]
` Summary of Safety and Effectiveness for Pronto V3™ Extraction
`Catheter
` Vascular Solutions 510(k) Summary (2007)
` VSIQXM_E00006018 – Guideliner Catheter Meeting Minutes for 2-
`4-09 [PROTECTIVE ORDER MATERIAL]
` VSIQXM_E00006016 – Project Development Requirements –
`GuideLiner [PROTECTIVE ORDER MATERIAL]
` VSIMDT00029969 – Vascular Solutions 2006 Budget
`[PROTECTIVE ORDER MATERIAL]
` VSIMDT00038731 – VSI 2007 Strategic Objectives [PROTECTIVE
`ORDER MATERIAL]
` VSIMDT00038765 – VSI 2008 Strategic Objectives [PROTECTIVE
`ORDER MATERIAL]
` VSIQXM_E00026409 – Document Change Order, GuideLiner
`Drawings (Shaft, Backbone) [PROTECTIVE ORDER MATERIAL]
` VSIQXM_E00006587 – GuideLiner Product Transfer Report
`[PROTECTIVE ORDER MATERIAL]
` VSIQXM_E00006202 – June 4, 2008 Memo: GuideLiner Marketing
`Plan [PROTECTIVE ORDER MATERIAL]
`[Intentionally left blank]
`
`1794-
`1799
`1800 Transcript from the November 24, 2020 deposition of Peter Keith
` Transcript from the November 19, 2020 deposition of Dr. John
`1801
`Graham
` Excerpt from Serruys' Handbook of Coronary Stents (4th edition)
`(2002)
` U.S. Patent No. 6,726,714 ("DiCaprio")
`
`1789
`
`1790
`
`1791
`
`1792
`
`1793
`
`1802
`
`1803
`
`9
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1805
`1806
`
`1807
`1808
`1809
`1810
`1811
`
`1818
`1819
`1820
`1821
`
`Exhibit Description
` Colombo et al, Selection of Coronary Stents, 40(6) Journal of the
`1804
`American College of Cardiology 1021-33 (2002)
` Transcript from the November 23, 2020 deposition of Peter Keith
` Declaration of Dr. Stephen Brecker in Connection with Petitioners’
`Reply
` Declaration of Michael Jones in Connection with Petitioners’ Reply
` U.S. Patent No. 6,849,068 ("Bagaoisan")
` U.S. Patent Publication 2004/0019310A1 ("Hogendijk '310")
` U.S. Patent Publication 2004/0054348A1 ("Hogendijk '348")
` Gorog et al, Distal Myocardial Protection During Percutaneous
`Coronary Intervention, 46(8) Journal of the American College of
`Cardiology 1434-45 (2005)
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` Transcript from the December 7, 2020 deposition of Craig
`Thompson, M.D.
` [Reserved]
` [Reserved]
` Transcript from the December 7, 2020 deposition of Lorenzo Azzalini
` Transcript from the October 30, 2019 deposition of Amy Welch (with
`redactions) Vascular Solutions LLC et al. v. Medtronic, Inc., 19:cv-
`01760-PJS-TNL [PROTECTIVE ORDER MATERIAL]
` VSIMDT00000831 (with redactions) [PROTECTIVE ORDER
`MATERIAL]
` VSIMDT00001100 (with redactions) [PROTECTIVE ORDER
`MATERIAL]
` Video Transcript of GuideLiner V3 Catheter: The Engineering Story
`
`1812
`1813
`1814
`1815
`1816
`1817
`
`1822
`
`1823
`
`1824
`
`10
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1826
`1827
`1828
`1829
`1830
`
`1831
`1832
`1833
`1834
`1835
`1836
`1837
`1838
`1839
`1840
`1841
`1842
`
`Exhibit Description
` Declaration of Peter A. Keith in Support of Defendants' Opposition to
`1825
`Plaintiff's Motion for Summary Judgment and Defendants' Cross
`Motion in QXMedical, LLC v. Vascular Solutions LLC et al., No.
`0:17-CV-01969 (PJS/TNL) (D. Minn.)
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` Declaration of Dr. Paul Zalesky in Connection with Petitioners’
`Reply
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` Originally filed Abstract, Specification, Drawings, and Claims from
`the ’032 File History
` Originally filed Abstract, Specification, Drawings, and Claims from
`the ’413 File History
`[Intentionally left blank]
`
`1843
`
`1844-
`1899
`1900
`1901
`
`[Reserved]
` [Reserved]
`
`11
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`1903
`1904
`1905
`1906
`
`1907
`1908
`1909
`1910
`1911
`1912
`1913
`1914
`1915
`1916
`1917
`1918
`1919
`
`Exhibit Description
` '380 Declaration of Dr. Brecker in Connection with Petitioners'
`1902
`Opposition to Patent Owner's Motion to Amend
` [Reserved]
` [Reserved]
` Dr. Hillstead Declaration from IPR2020-00136
` April 6, 2009 Applicant Amendment / Claims / Remarks from the
`’032 FH
` Dr. Hillstead Declaration from IPR2020-00129
` Excerpts from the ’379 File History
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` [Reserved]
` Declaration of Paul Zalesky in Support of Petitioners' Oppositions to
`Patent Owner's Motion to Amend
` Teleconference Transcript from February 2, 2021
` [Reserved]
` Transcript from the February 17, 2021 deposition of Peter T. Keith
` Email from Teleflex counsel sent on July 7, 2020 regarding Peterson
`Declaration
` Metadata of Ex. 2024
` LinkedIn profile of Dean Peterson
` Declaration of Dean Peterson
`12
`
`1920
`1921
`1922
`1923
`
`1924
`1925
`1926
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`
`Dated: February 23, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`Minneapolis, MN 55402
`Attorney for Petitioner
`
`13
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e)(4), the undersigned certifies that on
`
`February 23, 2021, a copy of PETITIONERS’ UPDATED EXHIBIT LIST was
`
`served in its entirety by electronic mail on Patent Owner’s counsel at the following
`
`addresses indicated in Patent Owner’s Mandatory Notices:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`dvandenburgh@carlsoncaspers.com
`
`Dennis C. Bremer, Reg. No. 40,528
`dbremer@carlsoncaspers.com
`
`Joseph W. Winkels
`jwinkels@carlsoncaspers.com
`
`Peter M. Kohlhepp
`pkohlhepp@carlsoncaspers.com
`
`Tara C. Norgard
`tnorgard@carlsoncaspers.com
`
`Alexander S. Rinn
`arinn@carlsoncaspers.com
`
`Megan E. Christner, Reg. No. 78,979
`mchristner@carlsoncaspers.com
`
`Kenneth E. Levitt, Reg. No. 39,747
`levitt.kenneth@dorsey.com
`
`14
`
`
`
`
`
`
`
`
`
`
`IPR2020-00128
`Patent RE 45,380
`
`Dated: February 23, 2021
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Attorney for Petitioner
`
`
`
`
`
`15
`
`